Félix Sancenon-Galarza

Engineering nanoparticle communication in living systems by stigmergy: An application to enhance antitumor therapy in triple-negative breast cancer

M. Orzáez, Juan F. Blandez, A. Lérida-Viso, 2023, Nano Today.

Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.

M. Orzáez, Juan F. Blandez, A. Lérida-Viso, 2022, Pharmacological research.